1. [Pharmacological treatment of Rett syndrome improves breathing and survival in a mouse model].
- Author
-
Roux JC and Villard L
- Subjects
- Adrenergic Uptake Inhibitors pharmacology, Animals, Brain Stem pathology, Brain Stem physiopathology, Cells, Cultured drug effects, Cells, Cultured metabolism, Desipramine pharmacology, Drug Evaluation, Preclinical, Female, Humans, Methyl-CpG-Binding Protein 2 deficiency, Methyl-CpG-Binding Protein 2 genetics, Methyl-CpG-Binding Protein 2 physiology, Mice, Mice, Knockout, Nerve Tissue Proteins deficiency, Neurons enzymology, Neurons pathology, Norepinephrine deficiency, Norepinephrine physiology, Respiration Disorders etiology, Rett Syndrome complications, Rett Syndrome genetics, Rett Syndrome physiopathology, Synaptic Vesicles drug effects, Synaptic Vesicles metabolism, Tyrosine 3-Monooxygenase deficiency, Adrenergic Uptake Inhibitors therapeutic use, Desipramine therapeutic use, Respiration Disorders drug therapy, Rett Syndrome drug therapy
- Published
- 2007
- Full Text
- View/download PDF